- Home
- TORO vs LTRN Comparison
TORO vs LTRN Comparison
Compare TORO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- LTRN
- Stock Information
- Founded
- TORO 2022
- LTRN 2013
- Country
- TORO Cyprus
- LTRN United States
- Employees
- TORO N/A
- LTRN N/A
- Industry
- TORO Marine Transportation
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- TORO Consumer Discretionary
- LTRN Health Care
- Exchange
- TORO Nasdaq
- LTRN Nasdaq
- Market Cap
- TORO 45.1M
- LTRN 37.2M
- IPO Year
- TORO N/A
- LTRN 2020
- Fundamental
- Price
- TORO $1.88
- LTRN $3.98
- Analyst Decision
- TORO
- LTRN Strong Buy
- Analyst Count
- TORO 0
- LTRN 1
- Target Price
- TORO N/A
- LTRN $25.00
- AVG Volume (30 Days)
- TORO 60.7K
- LTRN 40.3K
- Earning Date
- TORO 05-20-2025
- LTRN 05-15-2025
- Dividend Yield
- TORO N/A
- LTRN N/A
- EPS Growth
- TORO N/A
- LTRN N/A
- EPS
- TORO 1.09
- LTRN N/A
- Revenue
- TORO $22,394,283.00
- LTRN N/A
- Revenue This Year
- TORO N/A
- LTRN N/A
- Revenue Next Year
- TORO N/A
- LTRN N/A
- P/E Ratio
- TORO $1.78
- LTRN N/A
- Revenue Growth
- TORO 0.40
- LTRN N/A
- 52 Week Low
- TORO $1.70
- LTRN $2.55
- 52 Week High
- TORO $4.85
- LTRN $7.21
- Technical
- Relative Strength Index (RSI)
- TORO 40.31
- LTRN 57.30
- Support Level
- TORO $1.79
- LTRN $3.55
- Resistance Level
- TORO $2.03
- LTRN $4.43
- Average True Range (ATR)
- TORO 0.11
- LTRN 0.33
- MACD
- TORO 0.02
- LTRN 0.07
- Stochastic Oscillator
- TORO 37.50
- LTRN 66.72
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.